Results 31 to 40 of about 28,502 (229)
American journal of hematology/oncology, 2019 The association of thrombocytosis with iron deficiency anemia (IDA) is well‐recognized, but data describing the rate, predictors, and risk of thrombotic complications associated with IDA‐related thrombocytosis are limited.
Andrew B. Song +2 more
semanticscholar +1 more source
The impact of thrombocytosis on the long term outcomes in relapsed ovarian cancer [PDF]
Romanian Medical Journal, 2023 The presence of thrombocytosis has been widely associated with poor prognostic in patients diagnosed with ovarian cancer at the time of the initial diagnostic.
Irina Balescu +7 more
doaj +1 more source
Case Reports in Cardiology, 2013 The etiology of thrombocytosis can be classified into reactive and essential forms. The rate of thromboembolic events is higher in essential thrombocytosis, and these events include strokes, transient ischemic attacks, retinal artery or retinal vein ...
Nat Dumrongmongcolgul +8 more
doaj +1 more source
The British journal of general practice : the journal of the Royal College of General Practitioners, 2017 Background Thrombocytosis (raised platelet count) is an emerging risk marker of cancer, but the association has not been fully explored in a primary care context.
S. Bailey +3 more
semanticscholar +1 more source
Annals of Agricultural and Environmental Medicine, 2018 Introduction Thrombocytosis is a disease where the platelet count exceeds 600,000/μl. It is usually reactive in nature, less often clonal. Reactive thrombocytosis is usually a response to reactive inflammation or infection, splenectomy, iron deficiency,
Andrzej Jakub Sałacki +1 more
doaj +1 more source
Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma [PDF]
Investigative and Clinical Urology, 2016 Purpose: The aim of this study was to examine the association of preoperative thrombocytosis with the prognosis of patients with nonmetastatic renal cell carcinoma (RCC).
Jae Young Choi +2 more
doaj +1 more source
Imipenem–cilastatin-induced thrombocytosis: A probable rare case report
European Journal of Inflammation, 2022 Drug-induced thrombocytosis is difficult to identify and is rarely reported. Here, we report a probable rare case of imipenem–cilastatin-induced thrombocytosis in a 51-year-old female.
Huadong Chen +3 more
doaj +1 more source
Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer
Frontiers in Oncology, 2022 We investigated the incidence of reactive thrombocytosis after maximal cytoreductive surgery in advanced epithelial ovarian cancer (EOC) and its role in patient survival.
Myeong-Seon Kim +9 more
doaj +1 more source
Revista da Associação Médica Brasileira, 2023 We aimed to investigate the frequency and causes of thrombocytosis in patients admitted to the Department of Pediatric Hematology and Oncology of Elazig Fethi Sekin City Hospital, Elazig, Turkey.Between 2019 and 2021, the laboratory parameters of 2,500 patients admitted to the Hematology Department were studied.
Altay Babacan, Feray Ferda Şenol
openaire +2 more sources
Successful Treatment of Aplastic Anemia With Eltrombopag During Pregnancy: A Short Report. [PDF]
EJHaemABSTRACT Introduction Aplastic anemia (AA) is a rare bone marrow failure syndrome with pancytopenia, mainly due to immune‐mediated stem cell destruction. First‐line therapy for acquired severe AA ≥ 50 years/non‐severe AA (NSAA) requiring treatment is immunosuppressive therapy with horse anti‐thymocyte globulin, cyclosporine A (CSA), and eltrombopag ...
Frey SM +3 more
europepmc +2 more sources